Speaker illustration

Doctor Liang Xie

Nanjing Maternity and Child Health Care Hospital, Nanjing (China)

Member of:

European Society of Cardiology

Targeting the HIF-1/ASC pathway with dapagliflozin protects against sleep apnea-exacerbated myocardial damage in heart failure

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Heart failure therapies: current drug strategies

Thumbnail